脊柱裂囊肿的筛查。成本效益分析。
Screening for spina bifida cystica. A cost-benefit analysis.
作者信息
Hagard S, Carter F, Milne R G
出版信息
Br J Prev Soc Med. 1976 Mar;30(1):40-53. doi: 10.1136/jech.30.1.40.
Abstract
The costs and economic benefits are examined of introducing a programme for the mass-screening of pregnancies for the detection and abortion of fetuses with spina bifida cystica. A benefit-cost index is derived, and the possible effects on it of making different input assumptions are discussed. It is considered that, on economic grounds, screening may be worthwhile only in populations in which the incidence of spina bifida is high.
摘要
对推行一项针对孕期进行大规模筛查以检测并终止患有脊柱裂囊肿胎儿妊娠的计划的成本和经济效益进行了研究。得出了效益成本指数，并讨论了做出不同输入假设对其可能产生的影响。研究认为，从经济角度来看，只有在脊柱裂发病率较高的人群中进行筛查才可能是值得的。
相似文献
1
Screening for spina bifida cystica. A cost-benefit analysis.脊柱裂囊肿的筛查。成本效益分析。
Br J Prev Soc Med. 1976 Mar;30(1):40-53. doi: 10.1136/jech.30.1.40.
2
3
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Am J Obstet Gynecol. 1999 May;180(5):1227-33. doi: 10.1016/s0002-9378(99)70621-6.
4
5
Maternal serum alpha-fetoprotein and previous neural tube defects.孕妇血清甲胎蛋白与既往神经管缺陷
Br J Obstet Gynaecol. 1976 Mar;83(3):213-6. doi: 10.1111/j.1471-0528.1976.tb00811.x.
6
Feasibility of serum-alpha-fetoprotein screening for fetal neural-tube defects.血清甲胎蛋白筛查胎儿神经管缺陷的可行性
Lancet. 1977 May 21;1(8021):1098-9. doi: 10.1016/s0140-6736(77)92346-7.
7
Prenatal diagnosis and selective abortion for anencephaly and spina bifida.无脑儿和脊柱裂的产前诊断与选择性流产
Med J Aust. 1974 Apr 20;1(16):608-10. doi: 10.5694/j.1326-5377.1974.tb93200.x.
8
9
Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature.产前诊断无脑儿或脊柱裂后终止妊娠：文献系统评价
Birth Defects Res A Clin Mol Teratol. 2012 Nov;94(11):857-63. doi: 10.1002/bdra.23086. Epub 2012 Oct 25.
10
Letter: Ultrasound in diagnosis of spina bifida.
Lancet. 1975 Jun 14;1(7920):1336-7.
引用本文的文献
1
Genetics and the quality of life.
Soc Indic Res. 1980 Jan;7(1-4):419-41. doi: 10.1007/BF00305610.
2
Folic acid fortification of grain: an economic analysis.谷物的叶酸强化：一项经济分析。
Am J Public Health. 1995 May;85(5):667-76. doi: 10.2105/ajph.85.5.667.
3
Survival and handicap of infants with spina bifida.脊柱裂婴儿的生存与残疾情况
Arch Dis Child. 1980 Nov;55(11):845-50. doi: 10.1136/adc.55.11.845.
4
Measuring the benefits of screening for open neural tube defects.衡量开放性神经管缺陷筛查的益处。
J Epidemiol Community Health. 1982 Sep;36(3):214-9. doi: 10.1136/jech.36.3.214.
5
Essentials of health economics. Part V--Assessing the costs and benefits of treatment alternatives.《健康经济学要点》。第五部分——评估治疗方案的成本与效益
Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1561-3. doi: 10.1136/bmj.285.6354.1561.
6
How to read clinical journals: VII. To understand an economic evaluation (part A).如何阅读临床期刊：VII. 理解经济评估（A部分）。
Can Med Assoc J. 1984 Jun 1;130(11):1428-34.
7
Which prescriptive screening programmes are worth while?哪些规范性筛查项目是值得开展的？
J Epidemiol Community Health. 1984 Dec;38(4):270-7. doi: 10.1136/jech.38.4.270.
8
Can we afford screening for neural tube defects? The South Wales experience.我们能否承担神经管缺陷筛查的费用？南威尔士的经验。
Br Med J (Clin Res Ed). 1985 Jan 26;290(6464):293-5. doi: 10.1136/bmj.290.6464.293.
9
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.用于神经管缺陷的母血清甲胎蛋白筛查。德国一项联合研究的报告及神经管缺陷低出生患病率人群筛查的简短概述。
Hum Genet. 1985;69(1):47-61. doi: 10.1007/BF00295529.
10
本文引用的文献
1
Congenital malformations of the central nervous system in Scotland.苏格兰中枢神经系统的先天性畸形。
Br J Prev Soc Med. 1958 Jul;12(3):115-30. doi: 10.1136/jech.12.3.115.
2
The new late comers for antenatal care.产前检查的新迟到者。
Br J Prev Soc Med. 1970 Feb;24(1):52-7. doi: 10.1136/jech.24.1.52.
3
Spina bifida cystica and family stress.囊性脊柱裂与家庭压力
Br Med J. 1966 Sep 24;2(5516):757-60. doi: 10.1136/bmj.2.5516.757.
4
Confinement date unknown.分娩日期未知。
Nurs Times. 1971 Nov 11;67(45):1414-7.
5
Validation of screening procedures.筛查程序的验证
Br Med Bull. 1971 Jan;27(1):3-8. doi: 10.1093/oxfordjournals.bmb.a070810.
6
Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment.
Dev Med Child Neurol. 1971 Jun;13(3):279-303.
7
Spina bifida--and the parents.
Dev Med Child Neurol. 1971 Aug;13(4):462-76. doi: 10.1111/j.1469-8749.1971.tb03053.x.
8
An enquiry into the effect of a spina bifida child upon family life.
Dev Med Child Neurol. 1971 Aug;13(4):456-61. doi: 10.1111/j.1469-8749.1971.tb03052.x.
9
Meningomyelocele: the price of treatment.脊髓脊膜膨出：治疗的代价。
Br Med J. 1971 May 15;2(5758):385-7. doi: 10.1136/bmj.2.5758.385.
10
Handicap and social status of adults with spina bifida cystica.脊柱裂囊肿型成年患者的残疾状况与社会地位
Br J Prev Soc Med. 1974 May;28(2):85-92. doi: 10.1136/jech.28.2.85.
Zotero 插件